Todd Christopher Longsworth's most recent trade in NovoCure Ltd was a trade of 2,339 Ordinary Shares done at an average price of $70.1 . Disclosure was reported to the exchange on March 8, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 70.10 per share. | 08 Mar 2022 | 2,339 | 62,462 (0%) | 0% | 70.1 | 163,964 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 6,106 | 6,106 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 70.41 per share. | 03 Mar 2022 | 1,973 | 64,801 (0%) | 0% | 70.4 | 138,913 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 74.50 per share. | 03 Mar 2022 | 1,094 | 66,774 (0%) | 0% | 74.5 | 81,501 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Grant, award, or other acquisition of securities at price $ 137.12 per share. | 06 Jul 2021 | 154 | 67,868 (0%) | 0% | 137.1 | 21,117 | Ordinary Shares |
| NovoCure Ltd | Todd Christopher Longsworth | General Counsel | Sale of securities on an exchange or to another person at price $ 130.81 per share. | 08 Mar 2021 | 2,404 | 67,714 | - | 130.8 | 314,458 | Restricted Share Units |